Ads
related to: drugs, prostate cancer
Search results
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Zacks via Yahoo Finance· 3 days agoIt is also being evaluated for neuroendocrine prostate cancer in early-stage studies. Zacks Rank...
3 No-Brainer Stocks to Buy With $500 Right Now
The Motley Fool via AOL· 6 days agoThe core driver was its oncology segment, which delivered 19% operational sales growth. The superstar here was advanced prostate cancer drug< ...
PDS Biotechnology Corp. (NASDAQ:PDSB) Uses Cancer Immunotherapy to Infiltrate and Disable Tumors...
The Wall Street Transcript· 7 days agoDr. Frank Bedu-Addo has served as president and CEO of PDS Biotechnology...veteran biotech executive...
Council Post: The Business Case For Expanding Diversity In Clinical Trials
Forbes· 5 days agoBy now, you’ve heard why expanding representation in clinical trial populations matters for health...
FogPharma, Artbio join forces to design a different radiopharma drug
BioPharma Dive via Yahoo Finance· 7 days agoThe biotechs aim to marry FogPharma’s polypeptide science with Artbio’s lead-based...
Avoiding meat may reduce risk of heart disease, cancer, early death
UPI· 4 days agoStaying away from meat was tied to a reduced risk of heart disease, cancer and early death,...
Caris Life Sciences to Showcase Extensive Research Highlighting the Clinical Value of Comprehensive...
FOX 5 San Diego· 7 days agoCaris Life Sciences® (Caris), the leading next-generation AI TechBio company and precision medicine pioneer, today announced that the company and collaborators from the biopharma industry and ...
Natesto: Side effects and what to do about them
Medical News Today· 7 days agoNatesto (testosterone) is a brand-name nasal spray that’s prescribed to treat low testosterone in certain adults. As with other drugs, Natesto can cause...
Nuclear medicine booms in central Indiana - Indianapolis Business Journal
Indianapolis Business Journal· 4 days agoWhat’s inside, when the project is completed, will be large commercial batches of actinium 225, an...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoChicago, May 16, 2024 (GLOBE NEWSWIRE) -- Cancer Biomarkers market in terms of revenue was estimated to be worth $24.5 billion in 2024 and is poised to reach $42.0 billion ...